PubMed

The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome.

Oben J, Kuate D, Agbor G, Momo C, Talla X.

Lipids Health Dis. 2006 Sep 2;5:24.PMID: 16948861 [PubMed - indexed for MEDLINE]Related articlesFree article

The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study.

Oben JE, Ngondi JL, Momo CN, Agbor GA, Sobgui CS.

Lipids Health Dis. 2008 Mar 31;7:12.PMID: 18377661 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress.

Oben JE, Enyegue DM, Fomekong GI, Soukontoua YB, Agbor GA.

Lipids Health Dis. 2007 Feb 4;6:4.PMID: 17274828 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J; RIO-North America Study Group.

JAMA. 2006 Feb 15;295(7):761-75. Erratum in: JAMA. 2006 Mar 15;295(11):1252. PMID: 16478899 [PubMed - indexed for MEDLINE]Related articlesFree article

IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation.

Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE.

Lipids Health Dis. 2009 Mar 2;8:7.PMID: 19254366 [PubMed - indexed for MEDLINE]Related articlesFree article

[Pharmacological therapy of obesity]

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health.

Oben J, Enonchong E, Kuate D, Mbanya D, Thomas TC, Hildreth DJ, Ingolia TD, Tempesta MS.

Lipids Health Dis. 2007 Sep 5;6:20.PMID: 17803818 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial.

Salas-Salvadó J, Farrés X, Luque X, Narejos S, Borrell M, Basora J, Anguera A, Torres F, Bulló M, Balanza R; Fiber in Obesity-Study Group.

Br J Nutr. 2008 Jun;99(6):1380-7. Epub 2007 Nov 22.PMID: 18031592 [PubMed - indexed for MEDLINE]Related articles

Efficacy of 12 weeks supplementation of a botanical extract-based weight loss formula on body weight, body composition and blood chemistry in healthy, overweight subjects--a randomised double-blind placebo-controlled clinical trial.

Opala T, Rzymski P, Pischel I, Wilczak M, Wozniak J.

Eur J Med Res. 2006 Aug 30;11(8):343-50.PMID: 17052970 [PubMed - indexed for MEDLINE]Related articles

Effects of a vegetarian diet and treatment preference on biochemical and dietary variables in overweight and obese adults: a randomized clinical trial.

Burke LE, Hudson AG, Warziski MT, Styn MA, Music E, Elci OU, Sereika SM.

Am J Clin Nutr. 2007 Sep;86(3):588-96.PMID: 17823421 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the Metabolic Syndrome in overweight and obese women.

Meckling KA, Sherfey R.

Appl Physiol Nutr Metab. 2007 Aug;32(4):743-52.PMID: 17622289 [PubMed - indexed for MEDLINE]Related articles

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.

Després JP, Golay A, Sjöström L; Rimonabant in Obesity-Lipids Study Group.

N Engl J Med. 2005 Nov 17;353(20):2121-34.PMID: 16291982 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of weight loss on the metabolic syndrome.

Case CC, Jones PH, Nelson K, O'Brian Smith E, Ballantyne CM.

Diabetes Obes Metab. 2002 Nov;4(6):407-14.PMID: 12406040 [PubMed - indexed for MEDLINE]Related articles

The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome.

Katcher HI, Legro RS, Kunselman AR, Gillies PJ, Demers LM, Bagshaw DM, Kris-Etherton PM.

Am J Clin Nutr. 2008 Jan;87(1):79-90.PMID: 18175740 [PubMed - indexed for MEDLINE]Related articlesFree article

Phellodendron and Citrus extracts benefit cardiovascular health in osteoarthritis patients: a double-blind, placebo-controlled pilot study.

Oben J, Enonchong E, Kothari S, Chambliss W, Garrison R, Dolnick D.

Nutr J. 2008 May 20;7:16.PMID: 18492265 [PubMed - indexed for MEDLINE]Related articlesFree article

Analysis of weight loss outcomes using VLCD in black and white overweight and obese women with and without metabolic syndrome.

Hong K, Li Z, Wang HJ, Elashoff R, Heber D.

Int J Obes (Lond). 2005 Apr;29(4):436-42.PMID: 15711602 [PubMed - indexed for MEDLINE]Related articles

Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.

Hackman RM, Havel PJ, Schwartz HJ, Rutledge JC, Watnik MR, Noceti EM, Stohs SJ, Stern JS, Keen CL.

Int J Obes (Lond). 2006 Oct;30(10):1545-56. Epub 2006 Mar 21.PMID: 16552410 [PubMed - indexed for MEDLINE]Related articles

Use of polyglucosamine and physical activity to reduce body weight and dyslipidemia in moderately overweight subjects.

Cornelli U, Belcaro G, Cesarone MR, Cornelli M.

Minerva Cardioangiol. 2008 Oct;56(5 Suppl):71-8.PMID: 19597412 [PubMed - indexed for MEDLINE]Related articles

Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.

Eliasson B, Gudbjörnsdottir S, Cederholm J, Liang Y, Vercruysse F, Smith U.

Int J Obes (Lond). 2007 Jul;31(7):1140-7. Epub 2007 Feb 13.PMID: 17264849 [PubMed - indexed for MEDLINE]Related articles

Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia.

Lucas CP, Boldrin MN, Reaven GM.

Am J Cardiol. 2003 Apr 15;91(8):961-4.PMID: 12686336 [PubMed - indexed for MEDLINE]Related articles